Cannabix Technologies Inc.
CNSX : BLO
OTC PINK : BLOZF

Cannabix Technologies Inc.

October 21, 2015 08:00 ET

Cannabix Technologies Applauds Liberal Party Election Victory and Its Significance to Marijuana Legalization in Canada

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 21, 2015) - Cannabix Technologies Inc. (CSE:BLO)(OTC PINK:BLOZF) (the "Company"), reports that the Canadian federal election victory by Justin Trudeau and his Liberal Party presents a significant step forward in the potential legalization of marijuana in Canada. Prime Minister-Elect, Justin Trudeau has been outspoken about his support for the legalization of marijuana in Canada. During his campaign, Prime Minister-Elect, Trudeau promised to get to work "right away" towards legalizing marijuana. With this development in Canada and the continuing trend by various states in the United States to decriminalize recreational use of marijuana, Cannabix Technologies believes that its development of a marijuana breathalyzer is even more urgently needed to enforce marijuana impaired driving and road safety.

Cannabix is focused on developing a hand held breathalyzer for law enforcement that can be used to gather evidence of marijuana impaired driving at the roadside. At present, there is no scientific and court accepted tool for law enforcement to gather evidence of marijuana impaired driving to support criminal charges. In addition, the court systems in North America have been reluctant to proceed with criminal charges against drivers arrested for driving under the influence of marijuana without scientific evidence to support such charges.

Cannabix is working to develop a hand held marijuana breathalyzer that will be similar to alcohol breathalyzers currently used by law enforcement. The Cannabix Marijuana Breathalyzer would be used to gather scientifically validated and court accepted evidence of marijuana impairment at the roadside.

Cannabix also reports that it has added Jared Boock, Ph.D. to its team of scientists. Dr. Boock holds a doctorate in Analytical Chemistry from the University of Florida and has extensive experience in working with high-field asymmetric waveform ion mobility spectrometry (FAIMS) based methods of detection of volatile compounds. Cannabix is excited to add Dr. Boock to its scientific team to enhance product development.

Cannabix is recognized as a first mover and leader in the development of a marijuana breathalyzer and is working to develop a court certifiable marijuana breathalyzer for use by law enforcement to enhance safety as various jurisdictions move towards the decriminalization of the recreational use of marijuana.

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established a diversified portfolio of breath testing technologies in the pursuit of bringing durable, portable hand-held tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many jurisdictions globally. Cannabix is working to develop drug-testing devices that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. These devices would be used to provide detection of use of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. In particular, Cannabix is focused on developing breath testing devices for THC detection that would target recent use of THC, (within a two hour time period at time of testing) in contrast to saliva or urine testing for THC which can test positive for periods long after intoxication has worn off. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.

We seek Safe Harbor.

On behalf of the Board of Directors

Kal Malhi, President

Cannabix Technologies Inc.

For further information, contact us at info@cannabixtechnologies.com.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as final development of a commercial or prototype product(s), successful trial or pilot of company technologies, no assurance that commercial sales of any kind actually materialize; no assurance the Company will have sufficient funds to complete product development. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks regarding protection of proprietary technology; (iii) the ability of the Company to complete financings; (v) the ability of the Company to develop and market its future product; and (vi) risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements and filings. There is no assurance that the marijuana breathalyzer business will provide any benefit to the Company, and no assurance that any proposed new products will be built or proceed. There is no assurance that existing "patent pending" technologies licensed by the Company will receive patent status by regulatory authorities. The Company is not currently selling commercial breathalyzers. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Contact Information